NOVA EYE MEDICAL LIMITED
ASX:EYEHealth Care Equipment & ServicesShare count grew 24% in 24 months; 1 cash raise in 24 months
Between August 2024 and September 2026, its latest share-count filing, NOVA EYE MEDICAL LIMITED's ordinary share count rose 24.4% to 285M shares. The company raised capital once in that period, a A$6.6M placement in January 2025. Options and rights on issue could convert into 49,000 new shares, representing 0.0% of current shares, none of which are in the money; no expiry date is on record for these securities. The latest cash report shows non-negative net cash flow, so no funding-runway figure applies. No proposed securities issues are pending.
Quick answers · 4
When did EYE last raise capital?
The last capital raise in Nova Eye Medical's filings is Placement of $6.6M announced 31 Jan 2025, one of 1 cash raises in 24 months.
How much placement capacity does EYE have left?
About 99% of the 15% placement capacity left, about 1% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How many options and rights does EYE have outstanding?
Unexercised options and rights equal 0% of Nova Eye Medical's shares on issue.
How much has EYE's share count grown?
Nova Eye Medical has 284.9M shares on issue as at 28 Oct 2026, up 24.4% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 22 Sept 2026 | 2A · quoted issue | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 2A |
| 5 Aug 2026 | 3H · cancellation | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 3H |
| 10 July 2026 | 2A · quoted issue | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 2A |
| 25 June 2026 | 3H · cancellation | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 3H |
| 25 June 2026 | 3H · cancellation | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 3H |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
1 cash raise in the last 24 months · 0 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 49k of it converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| EYEAC | Performance rights | Condition-triggered | — | — | 49k | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 27 Aug 2026 | Thomas Anthony Spurling | Buy on-market | 160k | — | — | $117k | 3Y notice |
| 1 Sept 2025 | Thomas Anthony Spurling | Buy off-market | 78k | — | — | — | 3Y notice |
| 4 Aug 2025 | Thomas Anthony Spurling | Other incentive | 300k | — | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.